经额颞入路无牵开器手术治疗鞍结节脑膜瘤:单中心经验
该单中心回顾性研究纳入2015至2022年36例经额颞入路行无牵开器手术的鞍结节脑膜瘤患者,评估全切除率、视力结局与并发症。全切除34例(94.4%),33例视力缺损患者中31例(93.9%)视力改善、2例(6.1%)不变,平均随访33个月无视力恶化、脑牵拉损伤、死亡及肿瘤复发。作者认为该入路无牵开器手术是治疗鞍结节脑膜瘤可靠的经颅选择。
要点
- 36例鞍结节脑膜瘤经额颞入路无牵开器手术,全切除34例(94.4%)。
- 33例视力缺损患者中31例(93.9%)视力改善、2例(6.1%)不变。
- 平均随访33个月无视力恶化、脑牵拉损伤、死亡及肿瘤复发。
核心结论
- 经额颞入路无牵开器手术是治疗鞍结节脑膜瘤可靠的经颅选择。
- 若采用文中所述手术策略,可获得高全切除率、良好视力结局和低并发症发生率。
研究设计与样本
- 单中心回顾性研究,2015至2022年纳入36例经额颞入路行无牵开器手术的鞍结节脑膜瘤患者。
- 主要结局指标为全切除率、视力结局和并发症。
主要发现
- 全切除34例(94.4%)。
- 33例视力缺损患者中视力改善31例(93.9%)、不变2例(6.1%)。
- 平均随访33个月,无患者出现视力恶化、脑牵拉损伤、死亡或肿瘤复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although technologic advances have improved the surgical outcomes of tuberculum sellae meningiomas (TSMs), the treatment of these tumors remains challenging given important neurovascular structures involvement. In this article, the authors retrospectively reviewed the effectiveness of retractorless surgery for TSMs via the frontolateral approach (FLA). METHODS: Between 2015 and 2022, 36 patients with TSMs underwent retractorless surgery via the FLA. The gross total resection (GTR) rates, visual outcomes, and complications were evaluated as the main outcome parameters. RESULTS: GTR was achieved in 34 patients (94.4%). Visual acuity improved in 93.9% (n = 31) of the 33 patients with visual deficits and remained unchanged in 6.1% (n = 2). No patients suffered from visual deterioration, brain retraction injury, mortality, and tumor recurrence in the mean follow-up duration of 33 months. CONCLUSIONS: Retractorless surgery via the FLA is a reliable transcranial option for the treatment of TSMs. High rates of GTR, excellent visual outcomes, and the low incidence of complications could be achieved if the surgical strategy mentioned in the article is adopted.
引用
- Yang T, Zhang N, Li D, et al. Retractorless Surgery for Tuberculum Sellae Meningiomas via the Frontolateral Approach: A Single Institution's Experience. World Neurosurg. 2023. PMID: 37295461. doi:10.1016/j.wneu.2023.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。